Esomeprazole Magnesium 20?mg ×?14 Packets Suspension Wholesale price comparison

Esomeprazole Magnesium 20?mg ×?14 Packets Suspension Wholesale price comparison

$2.00

Esomeprazole Magnesium for Delayed-Release Oral Suspension (brand name: Aishman) comes in 14 single-dose packets, each containing 20?mg of esomeprazole magnesium as a fine powder. Manufactured by Chengdu Yondong Bio?Pharma Co., Ltd. and approved by NMPA under H20233454. Ideal for research on proton pump inhibitors, acid-related gastrointestinal models, delayed-release formulations, and pharmacokinetics.?? Strictly for laboratory research use only.?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare

Description

Product Specifications

SpecificationDescription
Product NameEsomeprazole Magnesium for Delayed?Release Oral Suspension (Aishman)
Generic NameEsomeprazole Magnesium (trihydrate)
CAS Number217087-09-7
FormulationDelayed?release oral suspension (powder to reconstitute)
Strength20?mg per packet × 14 packets (280?mg total)
Pack Size14 single-dose foil packets per box
Approval No.H20233454 (NMPA, China)
Product Code86902181000919
ManufacturerChengdu Yondong Bio?Pharma Co., Ltd.
Barcode6942715313010
Storage ConditionsStore below 30?°C, in a dry, cool place away from light
Intended UseFor laboratory research only

Mechanism of Action

Esomeprazole Magnesium is a proton pump inhibitor (PPI) that selectively and irreversibly inhibits the H?/K?-ATPase enzyme in gastric parietal cells, reducing gastric acid secretion. The delayed-release suspension ensures stability in the stomach and effective delivery in intestinal pH for absorption .


Research Applications & Pharmacology

  • Gastrointestinal Disease Modeling: Simulate GERD, gastric ulcers, erosive esophagitis.

  • Pharmacokinetics/Pharmacodynamics: Study absorption profiles in delayed-release formulations .

  • Drug Interaction Studies: Interactions with CYP2C19/CYP3A4 metabolic pathways .

  • Delayed?Release Formulation Research: Effects of ingestion method (oral vs tube administration) go.drugbank.com+2accessdata.fda.gov+2accessdata.fda.gov+2.

  • In Vitro/ In Vivo Models: Acid suppression, NSAID?induced ulcer mitigation, H. pylori studies in combination with antimicrobials en.wikipedia.org+4fda.report+4go.drugbank.com+4.


Safety Profile & Handling

  • Preclinical Effect Profile: Generally low toxicity; adverse effects may include acid suppression-related changes.

  • Handling Precautions: Use lab PPE (gloves, masks, lab coat). Avoid inhalation and contact with eyes or skin.

  • Storage Requirements: Store sealed, away from moisture and light. Use within specified stability time once opened.

  • Disposal: Dispose of any patient or test residues per hazardous waste regulations.


Core Keywords

Esomeprazole Magnesium, delayed-release suspension, PPI research, esomeprazole CAS 217087-09-7, lab use only, wholesale oral suspension, pharmaco?simulation, Chengdu Yondong esomeprazole


Research-Use Disclaimer

This product is intended exclusively for laboratory research purposes—non-clinical, non-diagnostic, and non-veterinary. Not approved for external use. Improper handling or use may pose risks; please follow institutional guidelines.

Additional information

Weight1 kg
Dimensions23 × 26 × 23 cm

Reviews

There are no reviews yet.

Be the first to review “Esomeprazole Magnesium 20?mg ×?14 Packets Suspension Wholesale price comparison”

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare